200 related articles for article (PubMed ID: 38129913)
1. In-silico guided chemical exploration of KDM4A fragments hits.
Lombino J; Vallone R; Cimino M; Gulotta MR; De Simone G; Morando MA; Sabbatella R; Di Martino S; Fogazza M; Sarno F; Coronnello C; De Rosa M; Cipollina C; Altucci L; Perricone U; Alfano C
Clin Epigenetics; 2023 Dec; 15(1):197. PubMed ID: 38129913
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic and structural studies of KDM-catalysed demethylation of histone 1 isotype 4 at lysine 26.
Walport LJ; Hopkinson RJ; Chowdhury R; Zhang Y; Bonnici J; Schiller R; Kawamura A; Schofield CJ
FEBS Lett; 2018 Oct; 592(19):3264-3273. PubMed ID: 30156264
[TBL] [Abstract][Full Text] [Related]
3. Lysine-241 Has a Role in Coupling 2OG Turnover with Substrate Oxidation During KDM4-Catalysed Histone Demethylation.
Hancock RL; Abboud MI; Smart TJ; Flashman E; Kawamura A; Schofield CJ; Hopkinson RJ
Chembiochem; 2018 May; 19(9):917-921. PubMed ID: 29443450
[TBL] [Abstract][Full Text] [Related]
4. Targeting lysine specific demethylase 4A (KDM4A) tandem TUDOR domain - A fragment based approach.
Upadhyay AK; Judge RA; Li L; Pithawalla R; Simanis J; Bodelle PM; Marin VL; Henry RF; Petros AM; Sun C
Bioorg Med Chem Lett; 2018 Jun; 28(10):1708-1713. PubMed ID: 29691138
[TBL] [Abstract][Full Text] [Related]
5. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.
Tan MK; Lim HJ; Harper JW
Mol Cell Biol; 2011 Sep; 31(18):3687-99. PubMed ID: 21768309
[TBL] [Abstract][Full Text] [Related]
6. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors.
King ON; Li XS; Sakurai M; Kawamura A; Rose NR; Ng SS; Quinn AM; Rai G; Mott BT; Beswick P; Klose RJ; Oppermann U; Jadhav A; Heightman TD; Maloney DJ; Schofield CJ; Simeonov A
PLoS One; 2010 Nov; 5(11):e15535. PubMed ID: 21124847
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Benzimidazole Pyrazolone Scaffold That Inhibits KDM4 Lysine Demethylases and Reduces Proliferation of Prostate Cancer Cells.
Carter DM; Specker E; Przygodda J; Neuenschwander M; von Kries JP; Heinemann U; Nazaré M; Gohlke U
SLAS Discov; 2017 Aug; 22(7):801-812. PubMed ID: 28346812
[TBL] [Abstract][Full Text] [Related]
8. The Activity of JmjC Histone Lysine Demethylase KDM4A is Highly Sensitive to Oxygen Concentrations.
Hancock RL; Masson N; Dunne K; Flashman E; Kawamura A
ACS Chem Biol; 2017 Apr; 12(4):1011-1019. PubMed ID: 28051298
[TBL] [Abstract][Full Text] [Related]
9. Reader domain specificity and lysine demethylase-4 family function.
Su Z; Wang F; Lee JH; Stephens KE; Papazyan R; Voronina E; Krautkramer KA; Raman A; Thorpe JJ; Boersma MD; Kuznetsov VI; Miller MD; Taverna SD; Phillips GN; Denu JM
Nat Commun; 2016 Nov; 7():13387. PubMed ID: 27841353
[TBL] [Abstract][Full Text] [Related]
10. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.
Van Rechem C; Black JC; Boukhali M; Aryee MJ; Gräslund S; Haas W; Benes CH; Whetstine JR
Cancer Discov; 2015 Mar; 5(3):255-63. PubMed ID: 25564516
[TBL] [Abstract][Full Text] [Related]
11. Advances in histone demethylase KDM4 as cancer therapeutic targets.
Lee DH; Kim GW; Jeon YH; Yoo J; Lee SW; Kwon SH
FASEB J; 2020 Mar; 34(3):3461-3484. PubMed ID: 31961018
[TBL] [Abstract][Full Text] [Related]
12. TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase.
Chandhasin C; Dang V; Perabo F; Del Rosario J; Chen YK; Filvaroff E; Stafford JA; Clarke M
Anticancer Drugs; 2023 Nov; 34(10):1122-1131. PubMed ID: 37067993
[TBL] [Abstract][Full Text] [Related]
13. Posttranslational modifications of the histone 3 tail and their impact on the activity of histone lysine demethylases in vitro.
Lohse B; Helgstrand C; Kristensen JB; Leurs U; Cloos PA; Kristensen JL; Clausen RP
PLoS One; 2013; 8(7):e67653. PubMed ID: 23844048
[TBL] [Abstract][Full Text] [Related]
14. A scintillation proximity assay for histone demethylases.
Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ
Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of PKF118-310 as a KDM4A inhibitor.
Franci G; Sarno F; Nebbioso A; Altucci L
Epigenetics; 2017 Mar; 12(3):198-205. PubMed ID: 27767379
[TBL] [Abstract][Full Text] [Related]
16. Analysis of JmjC Demethylase-Catalyzed Demethylation Using Geometrically-Constrained Lysine Analogues.
Langley GW; Brinkø A; Münzel M; Walport LJ; Schofield CJ; Hopkinson RJ
ACS Chem Biol; 2016 Mar; 11(3):755-62. PubMed ID: 26555343
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights into KDM4A driven genomic instability.
Young NL; Dere R
Biochem Soc Trans; 2021 Feb; 49(1):93-105. PubMed ID: 33492339
[TBL] [Abstract][Full Text] [Related]
18. The role of the histone demethylase KDM4A in cancer.
Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
[TBL] [Abstract][Full Text] [Related]
19. The lysine demethylase KDM4A controls the cell-cycle expression of replicative canonical histone genes.
Van Rechem C; Ji F; Mishra S; Chakraborty D; Murphy SE; Dillingham ME; Sadreyev RI; Whetstine JR
Biochim Biophys Acta Gene Regul Mech; 2020 Oct; 1863(10):194624. PubMed ID: 32798738
[TBL] [Abstract][Full Text] [Related]
20. KDM4 inhibitor SD49-7 attenuates leukemia stem cell
Li Y; Wang C; Gao H; Gu J; Zhang Y; Zhang Y; Xie M; Cheng X; Yang M; Zhang W; Li Y; He M; Xu H; Zhang H; Ji Q; Ma T; Ding S; Zhao Y; Gao Y
Theranostics; 2022; 12(11):4922-4934. PubMed ID: 35836814
[No Abstract] [Full Text] [Related]
[Next] [New Search]
